Gary Titus - Net Worth and Insider Trading

Gary Titus Net Worth

The estimated net worth of Gary Titus is at least $413,609 dollars as of 2024-11-06. Gary Titus is the Senior VP Finance & CFO of SciClone Pharmaceuticals Inc and owns about 37,095 shares of SciClone Pharmaceuticals Inc (SCLN) stock worth over $413,609. Details can be seen in Gary Titus's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gary Titus has not made any transactions after 2012-06-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gary Titus

To

Gary Titus Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gary Titus owns 3 companies in total, including EOM Pharmaceutical Holdings Inc (IMUC) , SciClone Pharmaceuticals Inc (SCLN) , and ARCA biopharma Inc (ABIO) .

Click here to see the complete history of Gary Titus’s form 4 insider trades.

Insider Ownership Summary of Gary Titus

Ticker Comapny Transaction Date Type of Owner
IMUC EOM Pharmaceutical Holdings Inc 2016-06-17 director & Chairman and Secretary
SCLN SciClone Pharmaceuticals Inc 2012-06-15 Senior VP Finance & CFO
ABIO ARCA biopharma Inc 2004-07-23 V.P. and Chief Acctg Officer

Gary Titus Latest Holdings Summary

Gary Titus currently owns a total of 1 stock. Gary Titus owns 37,095 shares of SciClone Pharmaceuticals Inc (SCLN) as of June 15, 2012, with a value of $413,609.

Latest Holdings of Gary Titus

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SCLN SciClone Pharmaceuticals Inc 2012-06-15 37,095 11.15 413,609

Holding Weightings of Gary Titus


Gary Titus Form 4 Trading Tracker

According to the SEC Form 4 filings, Gary Titus has made a total of 0 transactions in SciClone Pharmaceuticals Inc (SCLN) over the past 5 years. The most-recent trade in SciClone Pharmaceuticals Inc is the sale of 81,607 shares on June 15, 2012, which brought Gary Titus around $571,249.

Insider Trading History of Gary Titus

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gary Titus Trading Performance

GuruFocus tracks the stock performance after each of Gary Titus's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gary Titus is 17.66%. GuruFocus also compares Gary Titus's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gary Titus within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gary Titus's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gary Titus

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
5 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.06 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Gary Titus Ownership Network

Ownership Network List of Gary Titus

No Data

Ownership Network Relation of Gary Titus

Insider Network Chart

Gary Titus Owned Company Details

What does EOM Pharmaceutical Holdings Inc do?

Who are the key executives at EOM Pharmaceutical Holdings Inc?

Gary Titus is the director & Chairman and Secretary of EOM Pharmaceutical Holdings Inc. Other key executives at EOM Pharmaceutical Holdings Inc include VP & Product Development & Mfg. James G. Bender , and director & President & CEO Manish Singh .

EOM Pharmaceutical Holdings Inc (IMUC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of EOM Pharmaceutical Holdings Inc (IMUC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EOM Pharmaceutical Holdings Inc (IMUC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EOM Pharmaceutical Holdings Inc (IMUC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

EOM Pharmaceutical Holdings Inc Insider Transactions

No Available Data

Gary Titus Mailing Address

Above is the net worth, insider trading, and ownership report for Gary Titus. You might contact Gary Titus via mailing address: Sciclone Pharmaceuticals, Inc., 950 Tower Lane, Suite 900, Foster City Ca 94404-2125.